Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

To describe patient characteristics, adherence, and treatment patterns, among adult migraine patients in the United States prescribed erenumab.Migraine is a highly prevalent and debilitating disease characterized by recurrent attacks of moderate to severe headache accompanied by non-headache symptoms. Erenumab is a first-in-class calcitonin gene-related peptide receptor (CGRP-R) antagonist indicated for migraine prophylaxis in adults.This...